Literature DB >> 21153326

TNF-α and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy.

Joseli Lannes-Vieira1, Isabela Resende Pereira, Nathália Ferreira Vinagre, Lucia Elena Alvarado Arnez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21153326     DOI： 10.1007/978-1-4419-6612-4_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

1.  Antagonistic effect of atorvastatin on high fat diet induced survival during acute Chagas disease.

Authors:  Dazhi Zhao; Kezia Lizardo; Min Hui Cui; Kamalakar Ambadipudi; Jose Lora; Linda A Jelicks; Jyothi F Nagajyothi
Journal:  Microbes Infect       Date:  2016-07-12       Impact factor: 2.700

2.  Exhausted PD-1+ TOX+ CD8+ T Cells Arise Only in Long-Term Experimental Trypanosoma cruzi Infection.

Authors:  Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 3.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

4.  TNF-α is involved in the abnormal thymocyte migration during experimental Trypanosoma cruzi infection and favors the export of immature cells.

Authors:  Ana Rosa Pérez; Luiz Ricardo Berbert; Ailin Lepletier; Silvia Revelli; Oscar Bottasso; Suse Dayse Silva-Barbosa; Wilson Savino
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

5.  Influence of parasite load on renal function in mice acutely infected with Trypanosoma cruzi.

Authors:  Juliana Regina Dias Lemos; Wellington Francisco Rodrigues; Camila Botelho Miguel; Ricardo Cambraia Parreira; Renata Botelho Miguel; Alexandre de Paula Rogerio; Carlo Jose Freire Oliveira; Javier Emilio Lazo Chica
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.

Authors:  Isabela Resende Pereira; Glaucia Vilar-Pereira; Andrea Alice Silva; Otacilio Cruz Moreira; Constança Britto; Ellen Diana Marinho Sarmento; Joseli Lannes-Vieira
Journal:  Mediators Inflamm       Date:  2014-07-22       Impact factor: 4.711

7.  A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.

Authors:  Isabela Resende Pereira; Glaucia Vilar-Pereira; Virgínia Marques; Andrea Alice da Silva; Bráulia Caetano; Otacilio Cruz Moreira; Alexandre Vieira Machado; Oscar Bruna-Romero; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Joseli Lannes-Vieira
Journal:  PLoS Pathog       Date:  2015-01-24       Impact factor: 6.823

8.  Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.

Authors:  Andrea Alice Silva; Rafael Rodrigues Silva; Daniel Gibaldi; Rafael Meyer Mariante; Jessica Brandão Dos Santos; Isabela Resende Pereira; Otacílio Cruz Moreira; Joseli Lannes-Vieira
Journal:  J Neuroinflammation       Date:  2017-09-06       Impact factor: 8.322

9.  Enhanced Migratory Capacity of T Lymphocytes in Severe Chagasic Patients Is Correlated With VLA-4 and TNF-α Expression.

Authors:  Luiz Ricardo Berbert; Florencia Belén González; Silvina Raquel Villar; Carlos Vigliano; Susana Lioi; Juan Beloscar; Oscar Adelmo Bottasso; Suse Dayse Silva-Barbosa; Wilson Savino; Ana Rosa Pérez
Journal:  Front Cell Infect Microbiol       Date:  2021-11-02       Impact factor: 5.293

10.  Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease.

Authors:  Isabela Resende Pereira; Glaucia Vilar-Pereira; Andrea Alice da Silva; Joseli Lannes-Vieira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-06       Impact factor: 2.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.